Reviewing the Rationale for Cross-Shareholdings and Exercising Voting Rights
First written in FY2017. 7 of 11 entries say "Advanced", first in FY2019. Latest entry: 2026-09-29.
- FY2024AdvancedAnnual report
「During the fiscal year, after reviewing the significance of the holdings, we sold shares in 1 issue. In addition, shares in 1 issue were written off.」
Based on a review of the rationale for cross-held shares, 1 issue was sold and 1 issue was written off. At the end of the period, listed cross-held shares comprised 1 issue with a value of ¥538 million. - FY2023AdvancedAnnual report
「During the fiscal year, after reviewing the significance of the holdings, we sold shares in 2 issues. In addition, shares in 1 issue were transferred to EVIDENT Corporation.」
Based on a review of the rationale for cross-held shares, 2 issues were sold, and 1 issue was transferred to EVIDENT in connection with the spin-off of the scientific business. - FY2022AdvancedAnnual report
「During the fiscal year, after reviewing the significance of the holdings, we sold shares in 8 issues, including a partial sale of 1 issue.」
Based on a review of the rationale for cross-held shares, shares in 8 issues, including a partial sale of 1 issue, were sold. The sale proceeds were ¥828 million. - FY2021AdvancedAnnual report
「In fiscal 2020, after reviewing the significance of the holdings, we sold shares in 8 issues. In addition, shares in 3 issues were transferred to OM Digital Solutions on 1 January 2021.」
Based on a review of cross-held shares, 8 issues were sold, and 3 issues were transferred to OM Digital Solutions in connection with the transfer of the imaging business. - FY2020AdvancedAnnual report
「In fiscal 2019, we sold shares in 9 issues after reviewing the significance of holding them, including partial sales of 2 issues.」
The results of sales under the annual review policy for cross-held shares were described as sales of 9 issues, including partial sales of 2 issues. - FY2019AdvancedAnnual report
「In fiscal 2018, we sold shares in 12 issues after reviewing the significance of holding them.」
The results of sales under the annual review policy for cross-held shares were described as sales of 12 issues. - FY2018RestatedAnnual report
「Each year, the Board of Directors comprehensively considers the purpose of holding each cross-shareholding, the benefits and risks associated with the holding, and other factors to verify whether continued ownership is appropriate. Shares deemed unsuitable for continued ownership will be progressively reduced.」
The annual policy for reviewing the rationale for cross-held shares, exercising voting rights and reducing unnecessary holdings has been reiterated. - FY2017First statedAnnual report
「Each year, the Board of Directors verifies the rationality and necessity of holding major cross-held shares from a medium- to long-term perspective, taking into account the returns and risks of holding them, and confirms the purpose and rationale for holding them in light of this review.」
The policy for the Board of Directors’ annual review of the returns, risks and rationale for holding cross-held shares was described as an independent topic for the first time.